$BLD

Shoffner Jennifer sold (to issuer) 12,128 shares of BLD

Shoffner Jennifer (Vice President & CHRO) sold (to issuer) 12,128 shares of QXO Insulation, LLC (BLD) across 3 trades on 2026-07-01.

Original reporting
SEC EDGAR · Shoffner Jennifer
Published Jul 1, 2026, 9:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 9:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BLD
Neutral
medium confidence
Mentioned
$BLD
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLDNeutralLow
01

Why it matters

The newest fact is the CHRO’s sale of 12,128 shares to the issuer on 2026-07-01; no price is disclosed and the filing indicates no pre-arranged 10b5-1 plan.

02

Market read

Traders may note insider selling, but the disclosure lacks value/price and appears routine, so it’s unlikely to drive a sustained repricing.

03

What to watch

No 10b5-1 plan and holdings drop to 0 shares, but without price and with multiple same-day trades, it’s hard to infer timing or conviction.

Relevance 4/10Novelty 5/10Timing: filed 2026-07-01 (after-hours)

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for QXO Insulation, LLC (BLD).

Company-level read

Ticker impact

$BLDNeutralMedium confidence
Context

SEC Form 4 shows BLD VP & CHRO Jennifer Shoffner sold 12,128 shares to the issuer on 2026-07-01, with no 10b5-1 plan.

Expected impact

Likely minimal immediate impact; any effect would be sentiment-only and typically fades.

Evidence & confidence

The filing is a primary-source Form 4, but the transaction is small-to-moderate and lacks disclosed price/value and any stated catalyst beyond the sale code D.

Market effects

No sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Code D sales to issuer often reflect mechanical buyback participation rather than a bearish view; the lack of disclosed price/value reduces interpretability.

Key entities

  • BLD

    Subject of the Form 4 insider transaction; VP & CHRO sold shares to the issuer.

  • Jennifer Shoffner

    Vice President & CHRO who reported the sale to the issuer.

Related articles

$QXOMedAI 9/10

QXO Inc. (QXO) Launches Cash Tender Offers for TopBuild (BLD) Senior Notes Amid Pending Acquisition

QXO Inc. said it launched cash tender offers and consent solicitations to buy TopBuild Corp.’s outstanding 4.125% notes due 2032 and 5.625% notes due 2034 as part of its pending acquisition of TopBuild. QXO offered $961.25 per $1,000 principal, plus $50 for early tenders ($1,011.25 total), and sought indenture amendments to remove a change-of-control offer and most restrictive covenants.

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law or fiduciary-duty issues in deals involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale for $16.50/share, and TopBuild’s proposed acquisition by QXO. The firm also flagged QXO’s merger with TopBuild and said it may seek higher consideration or additional disclosures.

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law violations and fiduciary-duty breaches involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale to a consortium led by its executives/directors for $16.50/share, and TopBuild’s proposed deal with QXO. TopBuild holders would choose $505 cash or 20.2 QXO shares per share.